By G HossainPosted on February 5, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake. BMS Beats Again Despite Eliquis and Cobenfy Disappointments Post navigation Eikon Clocks Largest IPO Since 2024, Generate Follows as IPO Tap OpensNovo Will Never Beat Lilly. Why Does It Have To?